• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Aging Dis May. Immune Characteristics of Patients With Coronavirus Disease 2019 (COVID-19)

tetano

Editor, Senior Moderator
Aging Dis


. 2020 May 9;11(3):642-648.
doi: 10.14336/AD.2020.0317. eCollection 2020 May.
Immune Characteristics of Patients With Coronavirus Disease 2019 (COVID-19)


Xiaotian Dong[SUP] 1 [/SUP], Mengyan Wang[SUP] 2 [/SUP], Shuangchun Liu[SUP] 1 [/SUP], Jiaqi Zhu[SUP] 1 [/SUP], Yanping Xu[SUP] 3 [/SUP], Hongcui Cao[SUP] 3 4 5 [/SUP], Lanjuan Li[SUP] 3 4 [/SUP]



Affiliations

Abstract

Up to now, little is known about the detailed immune profiles of COVID-19 patients from admission to discharge. In this study we retrospectively reviewed the clinical and laboratory characteristics of 18 COVID-19 patients from January 30, 2020 to February 21, 2020. These patients were divided into two groups; group 1 had a severe acute respiratory syndrome coronavirus 2 nucleic acid-positive duration for more than 15 days (n = 6) and group 2 had a nucleic acid-positive duration for less than 15 days (n = 12). Group 1 patients had lower level of peripheral blood lymphocytes (0.40 vs. 0.78 ?10[SUP]9[/SUP]/L, p = 0.024) and serum potassium (3.36 vs. 3.79 mmol/L, p = 0.043) on admission but longer hospitalization days (23.17 vs. 15.75 days, p < 0.001) compared to Group 2 patients. Moreover, baseline level of lymphocytes (r = -0.62, p = 0.006) was negatively correlated with the nucleic acid-positive duration. Additionally, lymphocytes (420.83 vs. 1100.56 /μL), T cells (232.50 vs. 706.78 /μL), CD4[SUP]+[/SUP] T cells (114.67 vs. 410.44 /μL), and CD8[SUP]+[/SUP] T cells (94.83 vs. 257.44 /μL) in the peripheral blood analyzed by flow cytometry were significantly different between Group 1and Group 2. Furthermore, there was also a negative correlation between lymphocytes (r = -0.54, p = 0.038) or T cells (r = -0.55, p = 0.034) at diagnosis and the nucleic acid-positive duration, separately. In conclusion, the patients with nucleic acid-positive ≥ 15 days had significantly decreased lymphocytes, T cell and its subsets compared to those who remained positive for less than 15 days.

Keywords: coronavirus disease 2019 (COVID-19); immune characteristics; lymphocyte subsets; serum potassium.
 
Back
Top